| Seminars are presented by AFRRI researchers and other members of the scientific community. While some seminars are open to the public, others are limited to specific audiences. Any exceptions to time, place, and admittance are noted with each item. We do not record or distribute information presented in our Seminar Program. However, where available, references to related information are provided with the seminar title. |
- Friday, February 10: Natalia I. Ossetrova, PhD, Research Biologist, Biological Dosimetry Program, AFRRI: Further evaluation of combined proteomic and hematological approach for biodosimetry applications. Related information:
- Friday, February 3: MAJ Eric D. Lombardini, VMD, Chief, Division of Comparative Pathology, Veterinary Sciences Department, AFRRI: Tissue collection for histopathology in various laboratory species. Related information:
- Friday, January 13: Juliann G. Kiang, PhD, Senior Principal Investigator, Combined Injury Program, AFRRI: Ciprofloxacin as a drug to treat radiation combined injury. Related information:
- Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat shock protein 90 kDa after ionizing radiation. Radiat Res., 176:333–345, 2011.
- Radiation combined injury: DNA damage, apoptosis, and autophagy. Adapt Med., 2:1–10, 2010.
- Wound trauma increases radiation-induced mortality by increasing iNOS, cytokine concentrations, and bacterial infections. Radiate Res., 173:319–332, 2010.
- Friday, January 20: Nikolai Gorbunov, PhD, Henry M. Jackson Foundation (Combined Injury Program, AFRRI), Bethesda, MD: Response of mouse mesenchymal stromal cells (MSCs) to challenge with Escherichia coli: A proposed defense role of MSCs in the tissue barriers. Related information:
|